diazoxide has been researched along with Infant, Premature, Diseases in 6 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
Infant, Premature, Diseases: Diseases that occur in PREMATURE INFANTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the study was to characterize factors that may serve as clinical tools to identify neonates with transient neonatal hyperinsulinism hypoglycemia (HH) who may benefit from diazoxide treatment." | 7.96 | Higher C-peptide levels and glucose requirements may identify neonates with transient hyperinsulinism hypoglycemia who will benefit from diazoxide treatment. ( Davidov, AS; Elkon-Tamir, E; Eyal, O; Haham, A; Lebenthal, Y; Mandel, D; Oren, A; Shefer, G; Weintrob, N, 2020) |
| "The aim of the study was to characterize factors that may serve as clinical tools to identify neonates with transient neonatal hyperinsulinism hypoglycemia (HH) who may benefit from diazoxide treatment." | 3.96 | Higher C-peptide levels and glucose requirements may identify neonates with transient hyperinsulinism hypoglycemia who will benefit from diazoxide treatment. ( Davidov, AS; Elkon-Tamir, E; Eyal, O; Haham, A; Lebenthal, Y; Mandel, D; Oren, A; Shefer, G; Weintrob, N, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davidov, AS | 1 |
| Elkon-Tamir, E | 1 |
| Haham, A | 1 |
| Shefer, G | 1 |
| Weintrob, N | 1 |
| Oren, A | 1 |
| Lebenthal, Y | 1 |
| Mandel, D | 1 |
| Eyal, O | 1 |
| Prado, LA | 1 |
| Castro, M | 1 |
| Weisz, DE | 1 |
| Jain, A | 1 |
| Belik, J | 1 |
| Keyes, ML | 1 |
| Healy, H | 1 |
| Sparger, KA | 1 |
| Orth, LE | 1 |
| Geha, M | 1 |
| Roumiantsev, S | 1 |
| Matute, JD | 1 |
| Blanco, M | 1 |
| Khan, O | 1 |
| Stanley, K | 1 |
| Hageman, JR | 1 |
| Greeley, SA | 1 |
| Hussain, K | 1 |
| Aynsley-Green, A | 1 |
| Milsap, RL | 1 |
| Auld, PA | 1 |
6 other studies available for diazoxide and Infant, Premature, Diseases
| Article | Year |
|---|---|
Higher C-peptide levels and glucose requirements may identify neonates with transient hyperinsulinism hypoglycemia who will benefit from diazoxide treatment.
Topics: Adult; Blood Glucose; C-Peptide; Case-Control Studies; Diazoxide; Female; Gestational Age; Humans; H | 2020 |
Necrotising enterocolitis in newborns receiving diazoxide.
Topics: Canada; Correlation of Data; Diazoxide; Enterocolitis, Necrotizing; Female; Gastrointestinal Tract; | 2021 |
Necrotizing Enterocolitis in Neonates With Hyperinsulinemic Hypoglycemia Treated With Diazoxide.
Topics: Congenital Hyperinsulinism; Diazoxide; Enterocolitis, Necrotizing; Fatal Outcome; Female; Humans; In | 2021 |
Hyperinsulinism in a neonate.
Topics: Blood Glucose; Diagnosis, Differential; Diazoxide; Humans; Hyperinsulinism; Infant, Newborn; Infant, | 2014 |
Hyperinsulinaemic hypoglycaemia in preterm neonates.
Topics: Birth Weight; Chlorothiazide; Diazoxide; Diuretics; Female; Glucose; Humans; Hyperinsulinism; Hypogl | 2004 |
Neonatal hyperglycemia following maternal diazoxide administration.
Topics: Adult; Blood Glucose; Diazoxide; Female; Humans; Hyperglycemia; Hypertension; Infant, Newborn; Infan | 1980 |